Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System

NCT03371225 is registered in ClinicalTrials.gov with Spaulding Rehabilitation Hospital as lead sponsor.

NCT NCT03371225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03371225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System
Lead sponsor
Spaulding Rehabilitation Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2019
Completion date
October 26, 2025
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia